AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 2,850.8%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 2,850.82% |
Nexalin Technology (NXLIW) | 2,408.45% |
Spectaire (SPECW) | 1,150% |
Palladyne AI (PDYNW) | 999% |
Onconova Therapeutics (ONTX) | 986.15% |
Binah Capital Group, Inc Warrants (BCGWW) | 943.48% |
Breeze Holdings Acquisition (BREZW) | 807.69% |
LENZ Therapeutics (LENZ) | 769.71% |
Janone (JAN) | 761.26% |
Airship AI (AISPW) | 755.07% |
Codere Online Luxembourg SA Warrants (CDROW) | 748.66% |
AdTheorent (ADTHW) | 703.23% |
Armada Acquisition Corp I Warrant (AACIW) | 700% |
Elevation Oncology (ELEV) | 618.52% |
Swvl (SWVL) | 616.88% |
SRAX (SRAX) | 564.34% |
Inception Growth Acquisition Limited Warrants (IGTAW) | 557.89% |
Digital Health Acquisition Corp Warrant (DHACW) | 547.04% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
NorthView Acquisition Corporation Warrant (NVACW) | 540% |
PHP Ventures Acquisition Corp Warrants (PPHPW) | 530% |
Zivo Bioscience (ZIVO) | 492.59% |
Landos Biopharma (LABP) | 491.47% |
Corbus Pharmaceuticals (CRBP) | 491.35% |
Bone Biologics Corp Warrants (BBLGW) | 490.92% |